Natural History Study and Establishment of a Biorepository-TANGO2-related Disorder
Launched by BAYLOR COLLEGE OF MEDICINE · May 13, 2022
Trial Information
Current as of July 04, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding a condition called TANGO2-related Disorder, which is caused by specific changes in the TANGO2 gene. Researchers aim to create a collection of biological samples, known as a biorepository, from individuals who have this genetic disorder. This collection will help scientists study the disease and build a detailed database to learn more about how it affects patients over time.
The trial is currently looking for participants of all ages who have been diagnosed with TANGO2-related Disorder due to changes in the TANGO2 gene. If your child or a family member has this condition, they may be eligible to join the study. Participants can expect to provide samples and information that will contribute to important research. This is a great opportunity to help advance our understanding of this disorder and potentially improve care for others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients with pathogenic TANGO2 variants will be included.
- Exclusion Criteria:
- • Patients who do not have TANGO2-related disease will be excluded.
About Baylor College Of Medicine
Baylor College of Medicine is a leading academic institution dedicated to advancing health through innovative research, education, and clinical care. Located in Houston, Texas, it is renowned for its commitment to excellence in medical education and translational research, fostering collaborations that bridge laboratory discoveries with clinical application. As a clinical trial sponsor, Baylor College of Medicine leverages its robust infrastructure, interdisciplinary expertise, and access to diverse patient populations to conduct cutting-edge clinical studies aimed at improving patient outcomes and enhancing therapeutic approaches across a wide range of medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials